Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Brian Sauer

Concepts (390)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Arthritis, Rheumatoid
42
2024
1092
6.350
 Why?
Antirheumatic Agents
24
2024
278
5.800
 Why?
Veterans
32
2023
1398
4.180
 Why?
Spondylitis, Ankylosing
5
2020
46
2.510
 Why?
Hyperkalemia
3
2023
24
2.410
 Why?
Veterans Health
8
2023
178
2.220
 Why?
United States Department of Veterans Affairs
12
2021
635
2.030
 Why?
Methotrexate
10
2021
249
1.900
 Why?
Medication Adherence
7
2019
558
1.440
 Why?
Spondylarthritis
3
2020
45
1.330
 Why?
Natural Language Processing
4
2023
94
1.300
 Why?
Registries
18
2024
1896
1.290
 Why?
Rheumatology
2
2020
106
1.260
 Why?
Biological Products
6
2021
202
1.230
 Why?
Drug-Related Side Effects and Adverse Reactions
5
2019
253
1.230
 Why?
Tumor Necrosis Factor-alpha
6
2024
1198
1.140
 Why?
Drug Substitution
3
2021
51
0.980
 Why?
Psoriasis
2
2015
87
0.910
 Why?
Aged
46
2024
22103
0.900
 Why?
Arthritis, Psoriatic
3
2019
20
0.860
 Why?
Lymphoma, Follicular
2
2021
38
0.860
 Why?
Sulfasalazine
3
2019
23
0.830
 Why?
Hydroxychloroquine
3
2019
55
0.800
 Why?
Misoprostol
1
2022
17
0.780
 Why?
HLA-B27 Antigen
3
2019
15
0.780
 Why?
Middle Aged
47
2024
31154
0.770
 Why?
Humans
96
2024
129650
0.770
 Why?
Lung Diseases, Interstitial
6
2024
616
0.760
 Why?
United States
31
2023
13903
0.740
 Why?
Databases, Factual
7
2018
1269
0.730
 Why?
Electronic Health Records
6
2023
975
0.730
 Why?
Cohort Studies
16
2024
5420
0.710
 Why?
Rituximab
2
2021
164
0.690
 Why?
Infliximab
3
2016
100
0.680
 Why?
Analgesics, Opioid
5
2020
913
0.680
 Why?
Practice Patterns, Physicians'
5
2019
1266
0.680
 Why?
Insurance Claim Review
2
2017
64
0.660
 Why?
Pharmaceutical Services
2
2019
81
0.650
 Why?
Buprenorphine
1
2023
162
0.640
 Why?
Algorithms
5
2020
1622
0.640
 Why?
Prostatic Neoplasms, Castration-Resistant
1
2019
44
0.630
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2022
339
0.630
 Why?
Treatment Outcome
19
2024
10230
0.630
 Why?
Arthritis
2
2021
90
0.620
 Why?
Male
54
2024
63681
0.620
 Why?
Datasets as Topic
1
2019
110
0.610
 Why?
Anemia, Iron-Deficiency
1
2019
59
0.600
 Why?
Severity of Illness Index
12
2023
2742
0.590
 Why?
Antineoplastic Agents, Immunological
1
2020
181
0.590
 Why?
Etanercept
2
2016
56
0.590
 Why?
Adalimumab
2
2016
39
0.580
 Why?
Iron
2
2021
288
0.580
 Why?
Kidney Failure, Chronic
1
2022
547
0.540
 Why?
Renal Insufficiency, Chronic
2
2021
566
0.530
 Why?
Chronic Pain
3
2022
254
0.530
 Why?
Female
49
2024
68776
0.520
 Why?
Computer Simulation
4
2020
943
0.510
 Why?
Terminology as Topic
1
2017
204
0.500
 Why?
Opioid-Related Disorders
1
2023
484
0.490
 Why?
Delivery of Health Care
2
2022
894
0.490
 Why?
Diabetes Mellitus
3
2024
1001
0.480
 Why?
Cross-Over Studies
1
2017
521
0.480
 Why?
Risk Factors
23
2024
9765
0.470
 Why?
Healthcare Common Procedure Coding System
1
2014
1
0.470
 Why?
Research Design
3
2020
1044
0.460
 Why?
Insurance, Pharmaceutical Services
2
2011
23
0.450
 Why?
Adipokines
3
2022
47
0.440
 Why?
Cytokines
5
2024
2017
0.430
 Why?
Models, Statistical
2
2017
623
0.430
 Why?
Ambulatory Care
2
2014
504
0.420
 Why?
Narcotics
1
2013
47
0.420
 Why?
Hospitalization
5
2021
2070
0.420
 Why?
Emergency Service, Hospital
3
2023
1902
0.400
 Why?
Comparative Effectiveness Research
1
2013
149
0.400
 Why?
Utah
7
2013
64
0.400
 Why?
Potassium
2
2023
143
0.390
 Why?
Drug Prescriptions
2
2013
248
0.390
 Why?
Remission Induction
3
2022
272
0.380
 Why?
Pharmaceutical Preparations
3
2022
171
0.380
 Why?
Time Factors
11
2021
6556
0.380
 Why?
Medicine
1
2013
119
0.370
 Why?
Decision Support Systems, Clinical
2
2012
205
0.370
 Why?
Drug Overdose
2
2012
322
0.370
 Why?
Health Services Accessibility
2
2019
902
0.370
 Why?
Proportional Hazards Models
8
2022
1201
0.370
 Why?
Carpal Bones
2
2021
14
0.360
 Why?
Cardiovascular Diseases
8
2023
2004
0.350
 Why?
Inflammatory Bowel Diseases
1
2015
320
0.340
 Why?
Disease Progression
2
2018
2635
0.340
 Why?
Retrospective Studies
18
2023
14518
0.340
 Why?
Potentially Inappropriate Medication List
2
2020
16
0.330
 Why?
Practice Guidelines as Topic
2
2019
1501
0.330
 Why?
Adiponectin
4
2024
235
0.330
 Why?
Quality Indicators, Health Care
1
2012
298
0.320
 Why?
C-Reactive Protein
4
2021
401
0.320
 Why?
Aged, 80 and over
13
2021
7086
0.310
 Why?
Risk Assessment
10
2021
3240
0.300
 Why?
Kaplan-Meier Estimate
3
2021
857
0.300
 Why?
Body Mass Index
6
2018
2273
0.290
 Why?
Incidence
9
2024
2644
0.290
 Why?
Antibodies, Monoclonal
1
2014
1367
0.290
 Why?
Prospective Studies
9
2024
7133
0.290
 Why?
Health Knowledge, Attitudes, Practice
2
2013
1279
0.280
 Why?
Pneumonia, Bacterial
2
2020
115
0.280
 Why?
ROC Curve
3
2019
503
0.280
 Why?
International Classification of Diseases
4
2023
122
0.270
 Why?
Arthrodesis
3
2021
31
0.260
 Why?
Multimorbidity
2
2023
46
0.260
 Why?
Managed Care Programs
1
2007
133
0.250
 Why?
Predictive Value of Tests
4
2020
1952
0.250
 Why?
Propensity Score
3
2020
265
0.240
 Why?
Drug Utilization
2
2018
171
0.240
 Why?
Drug Therapy, Combination
2
2019
1040
0.240
 Why?
Patient Admission
1
2007
182
0.240
 Why?
Embryo, Nonmammalian
2
2005
166
0.230
 Why?
Adult
16
2022
35576
0.230
 Why?
Gene Targeting
1
2004
82
0.230
 Why?
Alarmins
1
2024
24
0.230
 Why?
Data Mining
3
2023
110
0.220
 Why?
Interleukin-33
1
2024
48
0.220
 Why?
Regression Analysis
3
2018
993
0.220
 Why?
Embryo, Mammalian
1
2004
226
0.220
 Why?
Wrist
2
2021
54
0.210
 Why?
Neoplasms
5
2023
2470
0.210
 Why?
Poisson Distribution
2
2017
73
0.210
 Why?
Wrist Joint
2
2021
64
0.210
 Why?
Follow-Up Studies
7
2021
4897
0.200
 Why?
Weight Loss
2
2018
734
0.200
 Why?
Stroke
2
2021
1071
0.200
 Why?
Diclofenac
1
2022
15
0.200
 Why?
Rheumatic Diseases
1
2023
69
0.200
 Why?
Comorbidity
4
2023
1547
0.200
 Why?
Blood Sedimentation
2
2019
34
0.190
 Why?
Chemokines
2
2021
226
0.190
 Why?
Research Report
1
2022
76
0.190
 Why?
Confidence Intervals
2
2016
317
0.190
 Why?
Genetic Testing
1
2004
428
0.190
 Why?
Polymerase Chain Reaction
1
2004
1038
0.180
 Why?
Linear Models
3
2018
819
0.180
 Why?
Waldenstrom Macroglobulinemia
1
2021
11
0.180
 Why?
Multivariate Analysis
5
2018
1502
0.180
 Why?
Hospitals, Veterans
3
2018
255
0.180
 Why?
Maintenance Chemotherapy
1
2020
22
0.170
 Why?
Prescription Drugs
2
2012
112
0.170
 Why?
Cyclophosphamide
2
2021
232
0.170
 Why?
Prosthesis-Related Infections
1
2021
75
0.170
 Why?
Stem Cells
1
2004
577
0.170
 Why?
Arthritis, Infectious
1
2021
60
0.170
 Why?
Pneumonia, Staphylococcal
1
2020
20
0.170
 Why?
SEER Program
1
2020
206
0.160
 Why?
Neoplasm Grading
1
2020
285
0.160
 Why?
Transferrin
1
2019
42
0.160
 Why?
Bipolar Disorder
1
2021
235
0.160
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2020
112
0.160
 Why?
Ferritins
1
2019
58
0.160
 Why?
Inappropriate Prescribing
1
2019
53
0.150
 Why?
Arthroplasty, Replacement, Hip
1
2021
137
0.150
 Why?
Ranolazine
1
2018
25
0.150
 Why?
Angina, Stable
1
2018
17
0.150
 Why?
Geriatrics
1
2019
81
0.150
 Why?
Area Under Curve
1
2019
304
0.150
 Why?
Coronary Artery Disease
2
2022
679
0.150
 Why?
Drug Monitoring
2
2012
216
0.150
 Why?
Osteoarthritis
1
2020
167
0.150
 Why?
Methicillin-Resistant Staphylococcus aureus
2
2020
221
0.150
 Why?
Rheumatologists
1
2017
15
0.140
 Why?
Professional Practice Location
1
2017
29
0.140
 Why?
Heart Failure
2
2021
2150
0.140
 Why?
Anti-Citrullinated Protein Antibodies
1
2019
109
0.140
 Why?
Longitudinal Studies
4
2023
2717
0.140
 Why?
Brain Ischemia
1
2021
321
0.140
 Why?
Random Allocation
1
2018
346
0.140
 Why?
Sacroiliitis
1
2017
6
0.140
 Why?
Calcium Channel Blockers
1
2018
161
0.140
 Why?
Reverse Transcriptase Inhibitors
1
2018
83
0.140
 Why?
Feasibility Studies
2
2020
868
0.140
 Why?
Obesity, Abdominal
1
2017
47
0.140
 Why?
Communication
1
2023
846
0.140
 Why?
Population Surveillance
2
2012
439
0.140
 Why?
Recovery of Function
1
2021
642
0.140
 Why?
Neoplasm Metastasis
1
2019
610
0.140
 Why?
Protease Inhibitors
1
2018
106
0.140
 Why?
Leptin
3
2022
219
0.140
 Why?
Bias
3
2013
196
0.140
 Why?
Data Accuracy
1
2017
57
0.140
 Why?
Disability Evaluation
1
2018
284
0.130
 Why?
Precision Medicine
1
2020
387
0.130
 Why?
HIV Integrase Inhibitors
1
2018
69
0.130
 Why?
Travel
1
2017
122
0.130
 Why?
Prognosis
3
2020
3794
0.130
 Why?
Risk Management
2
2007
85
0.130
 Why?
Adverse Drug Reaction Reporting Systems
2
2007
74
0.130
 Why?
Neoplasm Staging
1
2020
1295
0.130
 Why?
Forecasting
1
2018
359
0.130
 Why?
Dose-Response Relationship, Radiation
1
2016
132
0.130
 Why?
Arthroplasty, Replacement, Knee
1
2021
305
0.130
 Why?
Adrenergic beta-Antagonists
1
2018
321
0.130
 Why?
Anti-Inflammatory Agents
2
2018
480
0.130
 Why?
Antimicrobial Stewardship
1
2018
104
0.130
 Why?
Cross-Sectional Studies
6
2024
5066
0.130
 Why?
Pain
1
2022
789
0.130
 Why?
Hypertension
2
2018
1242
0.130
 Why?
Fees, Pharmaceutical
1
2015
10
0.130
 Why?
Drug Administration Routes
1
2015
39
0.120
 Why?
Observational Studies as Topic
1
2016
110
0.120
 Why?
Anti-Retroviral Agents
1
2018
231
0.120
 Why?
Anti-Infective Agents
1
2018
248
0.120
 Why?
Hospital Mortality
1
2020
850
0.120
 Why?
Cause of Death
4
2023
393
0.120
 Why?
Health Care Costs
1
2018
367
0.120
 Why?
Cyclosporine
1
2016
263
0.120
 Why?
Cross Infection
1
2017
218
0.120
 Why?
Logistic Models
2
2018
1988
0.120
 Why?
Pseudomonas Infections
1
2017
221
0.120
 Why?
Recombination, Genetic
3
2005
190
0.120
 Why?
Obesity
2
2018
2883
0.120
 Why?
Suicide
1
2021
580
0.120
 Why?
Inflammation Mediators
1
2017
505
0.110
 Why?
Drug Administration Schedule
1
2016
769
0.110
 Why?
Quality Improvement
1
2022
1103
0.110
 Why?
Glucocorticoids
1
2018
575
0.110
 Why?
Guideline Adherence
1
2018
526
0.110
 Why?
Health Expenditures
1
2015
179
0.110
 Why?
Infusions, Intravenous
1
2014
400
0.110
 Why?
Prednisone
3
2021
233
0.110
 Why?
Telemedicine
1
2022
788
0.110
 Why?
Causality
1
2013
117
0.100
 Why?
HIV Infections
2
2018
2720
0.100
 Why?
Integrases
3
2005
119
0.100
 Why?
Diagnosis, Dual (Psychiatry)
1
2012
36
0.100
 Why?
Mortality
1
2015
307
0.100
 Why?
Adiposity
1
2017
504
0.100
 Why?
Socioeconomic Factors
2
2018
1214
0.100
 Why?
Pneumonia
1
2018
616
0.100
 Why?
Education, Medical, Continuing
1
2013
122
0.100
 Why?
Root Cause Analysis
1
2012
8
0.100
 Why?
Feedback
2
2023
162
0.100
 Why?
Prescription Drug Misuse
1
2012
39
0.100
 Why?
Florida
1
2012
93
0.100
 Why?
Occupational Injuries
1
2012
45
0.100
 Why?
Lung Neoplasms
2
2022
2344
0.100
 Why?
Lung Diseases
1
2018
742
0.100
 Why?
HIV-1
1
2018
836
0.090
 Why?
Health Personnel
1
2017
652
0.090
 Why?
Outpatients
1
2014
370
0.090
 Why?
Narration
1
2012
57
0.090
 Why?
Adolescent
5
2015
20393
0.090
 Why?
Internal Medicine
1
2013
247
0.090
 Why?
Antineoplastic Agents
1
2022
2061
0.090
 Why?
Osteoporotic Fractures
1
2012
57
0.090
 Why?
Risk
1
2013
854
0.090
 Why?
Reproducibility of Results
2
2016
3083
0.090
 Why?
Substance-Related Disorders
2
2023
1022
0.080
 Why?
Dose-Response Relationship, Drug
1
2014
2012
0.080
 Why?
Anti-Bacterial Agents
1
2020
1717
0.080
 Why?
Young Adult
3
2015
12426
0.080
 Why?
Blood Pressure
2
2018
1736
0.080
 Why?
Pattern Recognition, Automated
1
2008
75
0.070
 Why?
Sex Factors
3
2021
1968
0.070
 Why?
Catheter-Related Infections
1
2008
72
0.070
 Why?
Diagnosis, Computer-Assisted
1
2008
87
0.070
 Why?
Hospital Records
1
2007
11
0.070
 Why?
Cost Sharing
1
2007
14
0.070
 Why?
Financing, Personal
1
2007
26
0.070
 Why?
Referral and Consultation
1
2013
732
0.070
 Why?
Antihypertensive Agents
1
2011
485
0.070
 Why?
Biomarkers
3
2024
3973
0.070
 Why?
Nonlinear Dynamics
1
2007
89
0.070
 Why?
Machine Learning
2
2022
443
0.070
 Why?
Mutagenesis, Site-Directed
2
2005
361
0.070
 Why?
Insulin-Like Growth Factor I
2
1999
307
0.070
 Why?
Viral Proteins
2
1999
328
0.060
 Why?
Primary Health Care
2
2013
1680
0.060
 Why?
Artificial Intelligence
1
2008
246
0.060
 Why?
Drug Interactions
1
2007
394
0.060
 Why?
Respiratory Tract Diseases
2
2017
148
0.060
 Why?
Models, Theoretical
1
2008
547
0.060
 Why?
Blotting, Southern
1
2004
69
0.060
 Why?
Health Services Research
1
2007
391
0.060
 Why?
Chronic Disease
2
2022
1720
0.060
 Why?
Data Collection
1
2007
650
0.060
 Why?
Mass Screening
1
2012
1149
0.060
 Why?
Mental Disorders
1
2012
1030
0.060
 Why?
Myocardial Infarction
1
2011
1022
0.050
 Why?
Interleukin-17
1
2024
108
0.050
 Why?
Health Status
2
2018
755
0.050
 Why?
Vital Capacity
1
2023
291
0.050
 Why?
Acetazolamide
1
2022
24
0.050
 Why?
Odds Ratio
2
2018
1023
0.050
 Why?
Telomere Shortening
1
2022
20
0.050
 Why?
Medicare
1
2007
720
0.050
 Why?
Length of Stay
1
2007
1127
0.050
 Why?
Antimanic Agents
1
2021
18
0.050
 Why?
Lithium
1
2021
37
0.050
 Why?
Valproic Acid
1
2021
47
0.050
 Why?
Chlorambucil
1
2021
9
0.050
 Why?
Medication Therapy Management
1
2022
72
0.050
 Why?
Bendamustine Hydrochloride
1
2021
11
0.050
 Why?
Vidarabine
1
2021
30
0.050
 Why?
Bortezomib
1
2021
45
0.040
 Why?
Patient Discharge
2
2023
857
0.040
 Why?
Zebrafish
1
2005
458
0.040
 Why?
Pulmonologists
1
2020
15
0.040
 Why?
Data Display
1
2020
20
0.040
 Why?
Vincristine
1
2021
109
0.040
 Why?
Cerebrovascular Circulation
1
2022
226
0.040
 Why?
Computed Tomography Angiography
1
2021
115
0.040
 Why?
Quality Control
1
2020
163
0.040
 Why?
Magnetic Resonance Imaging
2
2022
3408
0.040
 Why?
Telomere
1
2022
232
0.040
 Why?
Pharmacists
1
2022
247
0.040
 Why?
Range of Motion, Articular
1
2021
366
0.040
 Why?
User-Computer Interface
1
2020
149
0.040
 Why?
Embryonic and Fetal Development
1
1999
94
0.040
 Why?
Bone Marrow Transplantation
1
2020
274
0.040
 Why?
Doxorubicin
1
2021
325
0.040
 Why?
Piperidines
1
2021
199
0.040
 Why?
Magnetic Resonance Angiography
1
2021
236
0.040
 Why?
Adenine
1
2021
256
0.040
 Why?
Dexamethasone
1
2021
346
0.040
 Why?
Time-to-Treatment
1
2019
180
0.040
 Why?
Patient Satisfaction
1
2022
634
0.040
 Why?
Cost-Benefit Analysis
1
2020
569
0.040
 Why?
Gene Dosage
1
1998
143
0.040
 Why?
Infant Mortality
1
1998
104
0.040
 Why?
Reoperation
1
2020
545
0.040
 Why?
Methicillin Resistance
1
2017
18
0.040
 Why?
Recurrence
1
2020
1007
0.030
 Why?
Gene Expression Regulation, Developmental
2
1999
821
0.030
 Why?
HIV Integrase
1
2018
70
0.030
 Why?
Rheumatic Nodule
1
2016
3
0.030
 Why?
Cardiovascular Agents
1
2018
156
0.030
 Why?
Absorptiometry, Photon
1
2017
248
0.030
 Why?
Critical Illness
1
2022
758
0.030
 Why?
Isoxazoles
1
2016
55
0.030
 Why?
Thinness
1
2016
89
0.030
 Why?
Nutrition Surveys
1
2017
260
0.030
 Why?
Body Weight
2
2016
940
0.030
 Why?
Viral Load
1
2018
448
0.030
 Why?
Rheumatoid Factor
1
2016
167
0.030
 Why?
Lymphoma
1
2016
196
0.030
 Why?
Community-Acquired Infections
1
2017
161
0.030
 Why?
Survival Analysis
1
2018
1274
0.030
 Why?
Peptides, Cyclic
1
2016
256
0.030
 Why?
Analysis of Variance
1
2018
1288
0.030
 Why?
Surveys and Questionnaires
2
2020
5406
0.030
 Why?
Leukemia
1
2016
230
0.030
 Why?
Quality of Health Care
1
2018
608
0.030
 Why?
Age Factors
1
2021
3144
0.030
 Why?
Life Style
1
2016
460
0.030
 Why?
Tomography, X-Ray Computed
1
2023
2535
0.030
 Why?
Workers' Compensation
1
2012
26
0.020
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2021
1565
0.020
 Why?
Inflammation
1
2022
2736
0.020
 Why?
Coroners and Medical Examiners
1
2011
7
0.020
 Why?
Death Certificates
1
2011
30
0.020
 Why?
Sampling Studies
1
2011
96
0.020
 Why?
Brain
1
2022
2679
0.020
 Why?
Smoking
1
2016
1501
0.020
 Why?
Prostatic Neoplasms
1
2016
1016
0.020
 Why?
Pancreatic Neoplasms
1
2016
882
0.020
 Why?
Medical Assistance
1
2007
10
0.020
 Why?
Quality of Life
1
2019
2704
0.020
 Why?
Models, Econometric
1
2007
33
0.020
 Why?
Psychoses, Substance-Induced
1
2007
14
0.020
 Why?
Deductibles and Coinsurance
1
2007
11
0.020
 Why?
Eligibility Determination
1
2007
63
0.020
 Why?
Child
1
2007
20883
0.020
 Why?
Inpatients
1
2011
467
0.020
 Why?
Evidence-Based Medicine
1
2011
718
0.020
 Why?
Costs and Cost Analysis
1
2007
201
0.020
 Why?
Delirium
1
2007
78
0.020
 Why?
Insurance Coverage
1
2007
219
0.020
 Why?
Blood Coagulation Disorders
1
2007
167
0.020
 Why?
beta-Galactosidase
1
2005
77
0.020
 Why?
HSP70 Heat-Shock Proteins
1
2005
69
0.010
 Why?
Mosaicism
1
2005
71
0.010
 Why?
Genes, Reporter
1
2005
267
0.010
 Why?
Animals, Genetically Modified
1
2005
229
0.010
 Why?
Sensitivity and Specificity
1
2008
1838
0.010
 Why?
Case-Control Studies
1
2011
3381
0.010
 Why?
Mice, Transgenic
2
1999
2119
0.010
 Why?
Hemorrhage
1
2007
678
0.010
 Why?
Recombinant Fusion Proteins
1
2005
643
0.010
 Why?
Liver
2
1999
1839
0.010
 Why?
Growth Disorders
1
1998
80
0.010
 Why?
Animals
3
2005
35361
0.010
 Why?
Mice
2
1999
16937
0.010
 Why?
RNA, Messenger
1
1998
2708
0.010
 Why?
Infant, Newborn
1
1998
5762
0.000
 Why?
Sauer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (390) concept(s)
_
Co-Authors Expand Description
See all (8) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)